U.S. Markets open in 3 hrs 51 mins

Protalix BioTherapeutics, Inc. (PLX.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA
Add to watchlist
1,890.00+65.00 (+3.56%)
At close: 5:24PM IDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1,825.00
Bid1,891.00 x 128000
Ask1,895.00 x 209400
Day's Range1,889.00 - 1,989.00
52 Week Range834.60 - 2,290.00
Avg. Volume114,914
Market Cap853.227M
Beta (5Y Monthly)2.86
PE Ratio (TTM)N/A
EPS (TTM)-0.22
Earnings DateMay 31, 2021 - Jun 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PLX: Target Action Date Four Weeks Away
    Zacks Small Cap Research

    PLX: Target Action Date Four Weeks Away

    By John Vandermosten, CFA NYSE:PLX READ THE FULL PLX RESEARCH REPORT 2020 Financial and Operational Review Protalix Biotherapeutics, Inc. (NYSE:PLX) announced its 2020 financial and operational results in a March 30, 2021 press release and filing of Form 10-K . The reports were followed by a conference call that morning which discussed recent achievements including results from clinical trials,

  • Protalix BioTherapeutics Reports Fiscal Year 2020 Financial and Business Results
    PR Newswire

    Protalix BioTherapeutics Reports Fiscal Year 2020 Financial and Business Results

    Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today reported financial results for the fiscal year ended December 31, 2020 and provided a business update on recent corporate and clinical developments.


    Protalix Biotherapeutics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 30, 2021 / Protalix Biotherapeutics, Inc. (AMEX:PLX) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 30, 2021 at 8:30 AM Eastern Time.